Report Cover

Global Alogliptin Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    6.25 Mg Tablet
    25 Mg Tablet
    12.5 Mg Tablet
    15 Mg Tablet
    Other

Segment by Application
    Diabetes
    Hypercholesterolemia
    Obesity
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Takeda
    Perrigo
    Hikma Pharmaceuticals
    Furiex Pharma
    Allergan
    Sanofi
1 Alogliptin Market Overview
    1.1 Product Overview and Scope of Alogliptin
    1.2 Alogliptin Segment by Type
        1.2.1 Global Alogliptin Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 6.25 Mg Tablet
        1.2.3 25 Mg Tablet
        1.2.4 12.5 Mg Tablet
        1.2.5 15 Mg Tablet
        1.2.6 Other
    1.3 Alogliptin Segment by Application
        1.3.1 Alogliptin Sales Comparison by Application: (2021-2027)
        1.3.2 Diabetes
        1.3.3 Hypercholesterolemia
        1.3.4 Obesity
        1.3.5 Other
    1.4 Global Alogliptin Market Size Estimates and Forecasts
        1.4.1 Global Alogliptin Revenue 2016-2027
        1.4.2 Global Alogliptin Sales 2016-2027
        1.4.3 Alogliptin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Alogliptin Market Competition by Manufacturers
    2.1 Global Alogliptin Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Alogliptin Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Alogliptin Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Alogliptin Manufacturing Sites, Area Served, Product Type
    2.5 Alogliptin Market Competitive Situation and Trends
        2.5.1 Alogliptin Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Alogliptin Players Market Share by Revenue
        2.5.3 Global Alogliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Alogliptin Retrospective Market Scenario by Region
    3.1 Global Alogliptin Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Alogliptin Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Alogliptin Market Facts & Figures by Country
        3.3.1 North America Alogliptin Sales by Country
        3.3.2 North America Alogliptin Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Alogliptin Market Facts & Figures by Country
        3.4.1 Europe Alogliptin Sales by Country
        3.4.2 Europe Alogliptin Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Alogliptin Market Facts & Figures by Region
        3.5.1 Asia Pacific Alogliptin Sales by Region
        3.5.2 Asia Pacific Alogliptin Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Alogliptin Market Facts & Figures by Country
        3.6.1 Latin America Alogliptin Sales by Country
        3.6.2 Latin America Alogliptin Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Alogliptin Market Facts & Figures by Country
        3.7.1 Middle East and Africa Alogliptin Sales by Country
        3.7.2 Middle East and Africa Alogliptin Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Alogliptin Historic Market Analysis by Type
    4.1 Global Alogliptin Sales Market Share by Type (2016-2021)
    4.2 Global Alogliptin Revenue Market Share by Type (2016-2021)
    4.3 Global Alogliptin Price by Type (2016-2021)

5 Global Alogliptin Historic Market Analysis by Application
    5.1 Global Alogliptin Sales Market Share by Application (2016-2021)
    5.2 Global Alogliptin Revenue Market Share by Application (2016-2021)
    5.3 Global Alogliptin Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Takeda
        6.1.1 Takeda Corporation Information
        6.1.2 Takeda Description and Business Overview
        6.1.3 Takeda Alogliptin Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Takeda Product Portfolio
        6.1.5 Takeda Recent Developments/Updates
    6.2 Perrigo
        6.2.1 Perrigo Corporation Information
        6.2.2 Perrigo Description and Business Overview
        6.2.3 Perrigo Alogliptin Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Perrigo Product Portfolio
        6.2.5 Perrigo Recent Developments/Updates
    6.3 Hikma Pharmaceuticals
        6.3.1 Hikma Pharmaceuticals Corporation Information
        6.3.2 Hikma Pharmaceuticals Description and Business Overview
        6.3.3 Hikma Pharmaceuticals Alogliptin Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Hikma Pharmaceuticals Product Portfolio
        6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
    6.4 Furiex Pharma
        6.4.1 Furiex Pharma Corporation Information
        6.4.2 Furiex Pharma Description and Business Overview
        6.4.3 Furiex Pharma Alogliptin Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Furiex Pharma Product Portfolio
        6.4.5 Furiex Pharma Recent Developments/Updates
    6.5 Allergan
        6.5.1 Allergan Corporation Information
        6.5.2 Allergan Description and Business Overview
        6.5.3 Allergan Alogliptin Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Allergan Product Portfolio
        6.5.5 Allergan Recent Developments/Updates
    6.6 Sanofi
        6.6.1 Sanofi Corporation Information
        6.6.2 Sanofi Description and Business Overview
        6.6.3 Sanofi Alogliptin Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Sanofi Product Portfolio
        6.6.5 Sanofi Recent Developments/Updates

7 Alogliptin Manufacturing Cost Analysis
    7.1 Alogliptin Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Alogliptin
    7.4 Alogliptin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Alogliptin Distributors List
    8.3 Alogliptin Customers

9 Alogliptin Market Dynamics
    9.1 Alogliptin Industry Trends
    9.2 Alogliptin Growth Drivers
    9.3 Alogliptin Market Challenges
    9.4 Alogliptin Market Restraints

10 Global Market Forecast
    10.1 Alogliptin Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Alogliptin by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Alogliptin by Type (2022-2027)
    10.2 Alogliptin Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Alogliptin by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Alogliptin by Application (2022-2027)
    10.3 Alogliptin Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Alogliptin by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Alogliptin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Alogliptin Sales (M Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Alogliptin Sales (M Pcs) Comparison by Application (2021-2027) Table 3. Global Alogliptin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Alogliptin Covered in This Study Table 5. Global Alogliptin Sales (M Pcs) of Key Manufacturers (2016-2021) Table 6. Global Alogliptin Sales Share by Manufacturers (2016-2021) Table 7. Global Alogliptin Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Alogliptin Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Alogliptin Average Price (US$/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Alogliptin Manufacturing Sites and Area Served Table 11. Manufacturers Alogliptin Product Type Table 12. Global Alogliptin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Alogliptin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alogliptin as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Alogliptin Sales by Region (2016-2021) & (M Pcs) Table 16. Global Alogliptin Sales Market Share by Region (2016-2021) Table 17. Global Alogliptin Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Alogliptin Sales by Country (2016-2021) & (M Pcs) Table 19. North America Alogliptin Sales Market Share by Country (2016-2021) Table 20. North America Alogliptin Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Alogliptin Revenue Market Share by Country (2016-2021) Table 22. Europe Alogliptin Sales by Country (2016-2021) & (M Pcs) Table 23. Europe Alogliptin Sales Market Share by Country (2016-2021) Table 24. Europe Alogliptin Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Alogliptin Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Alogliptin Sales by Region (2016-2021) & (M Pcs) Table 27. Asia Pacific Alogliptin Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Alogliptin Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Alogliptin Revenue Market Share by Region (2016-2021) Table 30. Latin America Alogliptin Sales by Country (2016-2021) & (M Pcs) Table 31. Latin America Alogliptin Sales Market Share by Country (2016-2021) Table 32. Latin America Alogliptin Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Alogliptin Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Alogliptin Sales by Country (2016-2021) & (M Pcs) Table 35. Middle East and Africa Alogliptin Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Alogliptin Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Alogliptin Revenue Market Share by Country (2016-2021) Table 38. Global Alogliptin Sales (M Pcs) by Type (2016-2021) Table 39. Global Alogliptin Sales Market Share by Type (2016-2021) Table 40. Global Alogliptin Revenue (Million US$) by Type (2016-2021) Table 41. Global Alogliptin Revenue Share by Type (2016-2021) Table 42. Global Alogliptin Price (US$/Pcs) by Type (2016-2021) Table 43. Global Alogliptin Sales (M Pcs) by Application (2016-2021) Table 44. Global Alogliptin Sales Market Share by Application (2016-2021) Table 45. Global Alogliptin Revenue (Million US$) by Application (2016-2021) Table 46. Global Alogliptin Revenue Share by Application (2016-2021) Table 47. Global Alogliptin Price (US$/Pcs) by Application (2016-2021) Table 48. Takeda Corporation Information Table 49. Takeda Description and Business Overview Table 50. Takeda Alogliptin Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 51. Takeda Alogliptin Product Table 52. Takeda Recent Developments/Updates Table 53. Perrigo Corporation Information Table 54. Perrigo Description and Business Overview Table 55. Perrigo Alogliptin Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 56. Perrigo Alogliptin Product Table 57. Perrigo Recent Developments/Updates Table 58. Hikma Pharmaceuticals Corporation Information Table 59. Hikma Pharmaceuticals Description and Business Overview Table 60. Hikma Pharmaceuticals Alogliptin Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 61. Hikma Pharmaceuticals Alogliptin Product Table 62. Hikma Pharmaceuticals Recent Developments/Updates Table 63. Furiex Pharma Corporation Information Table 64. Furiex Pharma Description and Business Overview Table 65. Furiex Pharma Alogliptin Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 66. Furiex Pharma Alogliptin Product Table 67. Furiex Pharma Recent Developments/Updates Table 68. Allergan Corporation Information Table 69. Allergan Description and Business Overview Table 70. Allergan Alogliptin Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 71. Allergan Alogliptin Product Table 72. Allergan Recent Developments/Updates Table 73. Sanofi Corporation Information Table 74. Sanofi Description and Business Overview Table 75. Sanofi Alogliptin Sales (M Pcs), Revenue (Million US$), Price (US$/Pcs) and Gross Margin (2016-2021) Table 76. Sanofi Alogliptin Product Table 77. Sanofi Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Alogliptin Distributors List Table 81. Alogliptin Customers List Table 82. Alogliptin Market Trends Table 83. Alogliptin Growth Drivers Table 84. Alogliptin Market Restraints Table 85. Global Alogliptin Sales Forecast by Type (2022-2027) & (M Pcs) Table 86. Global Alogliptin Sales Market Share Forecast by Type (2022-2027) Table 87. Global Alogliptin Revenue Forecast by Type (2022-2027) & (US$ Million) Table 88. Global Alogliptin Revenue Market Share Forecast by Type (2022-2027) Table 89. Global Alogliptin Sales Forecast by Application (2022-2027) & (M Pcs) Table 90. Global Alogliptin Sales Market Share Forecast by Application (2022-2027) Table 91. Global Alogliptin Revenue Forecast by Application (2022-2027) & (US$ Million) Table 92. Global Alogliptin Revenue Market Share Forecast by Application (2022-2027) Table 93. Global Alogliptin Sales Forecast by Region (2022-2027) & (M Pcs) Table 94. Global Alogliptin Sales Market Share Forecast by Region (2022-2027) Table 95. Global Alogliptin Revenue Forecast by Region (2022-2027) & (US$ Million) Table 96. Global Alogliptin Revenue Market Share Forecast by Region (2022-2027) Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Alogliptin Figure 2. Global Alogliptin Market Share by Type in 2020 & 2027 Figure 3. 6.25 Mg Tablet Product Picture Figure 4. 25 Mg Tablet Product Picture Figure 5. 12.5 Mg Tablet Product Picture Figure 6. 15 Mg Tablet Product Picture Figure 7. Other Product Picture Figure 8. Global Alogliptin Market Share by Application in 2020 & 2027 Figure 9. Diabetes Figure 10. Hypercholesterolemia Figure 11. Obesity Figure 12. Other Figure 13. Global Alogliptin Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Alogliptin Market Size 2016-2027 (US$ Million) Figure 15. Global Alogliptin Sales 2016-2027 (M Pcs) Figure 16. Global Alogliptin Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Alogliptin Sales Share by Manufacturers in 2020 Figure 18. Global Alogliptin Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Alogliptin Players: Market Share by Revenue in 2020 Figure 20. Alogliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Alogliptin Sales Market Share by Region (2016-2021) Figure 22. Global Alogliptin Sales Market Share by Region in 2020 Figure 23. Global Alogliptin Revenue Market Share by Region (2016-2021) Figure 24. Global Alogliptin Revenue Market Share by Region in 2020 Figure 25. U.S. Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. UAE Alogliptin Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Alogliptin by Type (2016-2021) Figure 50. Sales Market Share of Alogliptin by Application (2016-2021) Figure 51. Sales Market Share of Alogliptin by Application in 2020 Figure 52. Revenue Share of Alogliptin by Application (2016-2021) Figure 53. Revenue Share of Alogliptin by Application in 2020 Figure 54. Manufacturing Cost Structure of Alogliptin Figure 55. Manufacturing Process Analysis of Alogliptin Figure 56. Alogliptin Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us